@article {Asem2021.03.22.21253577, author = {Noha Asem and Mohamed Hassany and Khaled Taema and Hossam Masoud and Gehan Elassal and Ehab Kamal and Wagdy Amin and Akram Abdelbary and Amin Abdel Baki and Samy Zaky and Ahmad Abdalmohsen and Hamdy Ibrahim and Mohamed Elnady and Ahmed Mohamed and Ehab Atteia and Hala Zaid}, title = {Demographic and clinical features associated with in-hospital mortality in Egyptian COVID-19 patients: A retrospective cohort study}, elocation-id = {2021.03.22.21253577}, year = {2021}, doi = {10.1101/2021.03.22.21253577}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Introduction Since the worldwide emergence of the COVID-19, several protocols were used by different healthcare organisations. We evaluated in this study the demographic and clinical characteristics of COVID-19 disease in Egyptian population with special consideration for its mortality predictors.Methodology 8162 participants (mean age 48.7{\textpm}17.3 years,54.5\% males) with RT-PCR positive COVID-19 were included. The electronic medical records were reviewed for demographic, clinical, laboratory, and radiologic features. The primary outcome was the in-hospital mortality rate.Results The in-hospital mortality was 11.2\%. There was a statistically significant strong association of in-hospital mortality with age \>60 years old (OR:4.7; 95\% CI 4.1-5.4;p\<0.001), diabetes mellitus (OR:4.6; 95\% CI 3.99-5.32;p\<0.001), hypertension (OR:3.9; 95\% CI 3.4-4.5;p\<0.001), coronary artery disease (OR:2.7; 95\% CI 2.2-3.2;p\<0.001), chronic obstructive pulmonary disease (OR:2.1; 95\% CI 1.7-2.5;p\<0.001), chronic kidney disease (OR:4.8; 95\% CI 3.9-5.9;p\<0.001), malignancy (OR:3.7; 95\% CI 2.3-5.75;p\<0.001), neutrophil-lymphocyte ratio \>3.1 (OR:6.4; 95\% CI 4.4-9.5;P\< 0.001), and ground glass opacities (GGOs) in CT chest (OR:3.5; 95\% CI 2.84-4.4;P\<0.001), respectively. There was a statistically significant moderate association of in-hospital mortality with male gender (OR:1.6; 95\% CI 1.38-1.83;p\<0.001) and smoking (OR:1.6; 95\% CI 1.3-1.9;p\<0.001). GGOs was reported as the most common CT finding (occurred in 73.1\% of the study participants).Conclusions This multicenter, retrospective study ascertained the higher in-hospital mortality rate in Egyptian COVID-19 patients with different comorbidities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMinistry of health and populationAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:the research ethics committee and the institutional review board of the Egyptian Ministry of Health and PopulationAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data in the manuscript are available}, URL = {https://www.medrxiv.org/content/early/2021/03/25/2021.03.22.21253577}, eprint = {https://www.medrxiv.org/content/early/2021/03/25/2021.03.22.21253577.full.pdf}, journal = {medRxiv} }